Risk Predictors & Economics

PUBLICATIONS

2014
  • Chang Y, Gallon L, Jay C, Shetty K, Ho B, Levitsky J, et al. Comparative Effectiveness of Liver Transplant Strategies for End-Stage Liver Disease Patients on Renal Replacement Therapy. Liver Transpl. 2014.
  • Brown RS, Jr., Smith A, Dew MA, Gillespie BW, Hill-Callahan M, Ladner DP. Predictors of donor follow-up after living donor liver transplantation. Liver Transpl. 2014.
2013
  • Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, et al. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl. 2013;19(3):259-67.
  • Zapf M, Denham W, Barrera E, Butt Z, Carbray J, Wang C, et al. Patient-centered outcomes after laparoscopic cholecystectomy. Surg Endosc. 2013.
  • Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, et al. Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013;59(5):1029-36.
  • VanWagner LB, Skaro AI. Program-specific reports: implications and impact on program behavior. Curr Opin Organ Transplant. 2013;18(2):210-5.
  • Therasse A, Wallia A, Molitch ME. Management of post-transplant diabetes. Current diabetes reports. 2013;13(1):121-9.
  • Salem R, Gilbertsen M, Butt Z, Memon K, Vouche M, Hickey R, et al. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013;11(10):1358-65 e1.
  • Levitsky J, Oniscu GC. Meeting report of the International Liver Transplantation Society’s 18th annual international congress: Hilton San Francisco Hotel, San Francisco, CA, May 16-19, 2012. Liver Transpl. 2013;19(1):27-35.
  • Levitsky J, Doucette K. Viral hepatitis in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:147-68.
  • Levitsky J. Immunosuppression withdrawal following liver transplantation: The older, the wiser… but maybe too late. Hepatology. 2013.
  • Kia L, Shah SJ, Wang E, Sharma D, Selvaraj S, Medina C, et al. Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. Am J Transplant. 2013;13(9):2395-401.
  • Jay CL, Skaro AI. Comparative effectiveness research in liver transplantation: crossing the cost and quality chasm. Journal of comparative effectiveness research. 2013;2(1):7-9.
  • Chhabra D, Alvarado A, Dalal P, Leventhal J, Wang C, Sustento-Reodica N, et al. Impact of Calcineurin-Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone-Free Regimen. Am J Transplant. 2013.
2012
  • Tong A, Chapman J, Israni A, Gordon E, Craig J. Qualitative research in transplantation: Recent contributions to clinical care and policy American Journal of Transplantation. 2012:In Press.
  • Skaro AI, Wang E, Lyuksemburg V, Abecassis M. Donation after cardiac death liver transplantation: time for policy to catch up with practice. Liver Transpl. 2012;18(1):5-8.
  • Perumpail RB, Levitsky J, Wang Y, Lee VS, Karp J, Jin N, et al. MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. Acad Radiol. 2012;19(9):1121-6.
  • Levitsky J, Guckelberger O. Meeting report of the 2011 Joint International Congress of the International Liver Transplantation Society, the European Liver and Intestine Transplant Association, and the Liver Intensive Care Group of Europe. Liver Transpl. 2012;18(3):282-9.
  • Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, et al. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology. 2012;142(5):1132-9 e1.
  • Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, et al. Outcomes and native renal recovery following simultaneous liver-kidney transplantation. Am J Transplant. 2012;12(11):2949-57.
  • Jay CL, Skaro AI, Ladner DP, Wang E, Lyuksemburg V, Chang Y, et al. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl. 2012;18(6):630-40.
  • Chhabra D, Skaro AI, Leventhal JR, Dalal P, Shah G, Wang E, et al. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Clin J Am Soc Nephrol. 2012;7(3):504-12.
  • Baker TB, Abecassis M, Levitsky J. To kidney or not to kidney, when … is the question. Liver Transpl. 2012;18(8):875-7.
  • Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, et al. Solid-organ transplantation in older adults: current status and future research. Am J Transplant. 2012;12(10):2608-22.
2011
  • Tong A, Chapman J, Israni A, Gordon E, Craig J. Qualitative research in transplantation: Recent contributions to clinical care and policy American Journal of Transplantation. 2012:In Press.
  • Skaro AI, Wang E, Lyuksemburg V, Abecassis M. Donation after cardiac death liver transplantation: time for policy to catch up with practice. Liver Transpl. 2012;18(1):5-8.
  • Perumpail RB, Levitsky J, Wang Y, Lee VS, Karp J, Jin N, et al. MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. Acad Radiol. 2012;19(9):1121-6.
  • Levitsky J, Guckelberger O. Meeting report of the 2011 Joint International Congress of the International Liver Transplantation Society, the European Liver and Intestine Transplant Association, and the Liver Intensive Care Group of Europe. Liver Transpl. 2012;18(3):282-9.
  • Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, et al. Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology. 2012;142(5):1132-9 e1.
  • Levitsky J, Baker T, Ahya SN, Levin ML, Friedewald J, Gallon L, et al. Outcomes and native renal recovery following simultaneous liver-kidney transplantation. Am J Transplant. 2012;12(11):2949-57.
  • Jay CL, Skaro AI, Ladner DP, Wang E, Lyuksemburg V, Chang Y, et al. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl. 2012;18(6):630-40.
  • Chhabra D, Skaro AI, Leventhal JR, Dalal P, Shah G, Wang E, et al. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Clin J Am Soc Nephrol. 2012;7(3):504-12.
  • Baker TB, Abecassis M, Levitsky J. To kidney or not to kidney, when … is the question. Liver Transpl. 2012;18(8):875-7.
  • Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, et al. Solid-organ transplantation in older adults: current status and future research. Am J Transplant. 2012;12(10):2608-22.
  • Jay C, Skaro A, Ladner D, Lyuksemburg V, Kang R, Xu H, et al. The Comparative Effectiveness of Donation after Cardiac Death Liver Transplantation: The Cost and Quality Chasm Annals of Surgery. 2011.
  • Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011;58(3):223-31.
  • Colleen Jay, Vadim Lyuksemburg, Daniela Ladner, Edward Wang, Juan Caicedo , Jane Holl, Michael Abecassis, Anton Skaro. Ischemic Cholangiopathy After Controlled Donation After Cardiac Death Liver Transplantation: A Meta-analysis. Ann Surg. 2011 Feb;253(2):259-64.
  • Colleen Jay, Anton Skaro, Daniela Ladner, Edward Wang, Vadim Lyuksemburg, Raymond Kang, Joseph Feinglass, Jane Holl, Michael Abecassis. A Comprehensive Risk Assessment of Mortality Following Donation after Cardiac Death Liver Transplant – An Analysis of the National Registry. J Hepatol. 2011 Feb 18.
  • Jay C, Skaro A, Ladner D, Lyuksemburg V, Kang R, Xu X, et al. The Comparative Effectiveness of Donation after Cardiac Death Liver Transplantation according to Disease Severity: A Decision Analysis. Journal of Hepatology. 2011.
  • Gallon L, Chhabra D, Skaro AI. T-Cell-Depleting Agents in Kidney Transplantation: Is There a Place for Alemtuzumab? Am J Kidney Dis. 2011.
2010
  • Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation. 2010;89(2):222-6.
  • Thomasset SC, Butt Z, Liptrot S, Fairbrother BJ, Makhdoomi KR. Ultrasound guided foam sclerotherapy: factors associated with outcomes and complications. Eur J Vasc Endovasc Surg. 2010;40(3):389-92.
  • Skaro AI, Jay CL, Ladner D, Abecassis MM. Trends in donation after cardiac death and donation after brain death–reading between the lines. Am J Transplant. 2010;10(11):2390-1.
  • Pillai AA, Lee VS, Wang E, Rinella ME, Levitsky J. Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C. Transplant Proc. 2010;42(9):3647-51.
  • Leventhal JR, Paunescu S, Baker TB, Caciedo JC, Skaro A, Kocak B, et al. A decade of minimally invasive donation: experience with more than 1200 laparoscopic donor nephrectomies at a single institution. Clin Transplant. 2010;24(2):169-74.
  • Jay CL, Lyuksemburg V, Kang R, Preczewski L, Stroupe K, Holl JL, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg. 2010;251(4):743-8.
  • Fryer J, DaRosa DA, Wang E, Han L, Axelrod D, Ishitani M, et al. What defines a transplant surgeon? A needs assessment for curricular development in transplant surgery fellowship training. Am J Transplant. 2010;10(3):664-74.
  • Baker TB, Jay CL, Fryer JP, Abecassis MM. Transplant renoportal vein conduit for complete mesenteric thrombosis: a case report. Am Surg. 2010;76(9):1016-9.
  • Colleen Jay, Vadim Lyuksemburg, Raymond Kang, Luke Preczewski, Kevin Stroupe, Jane Holl, Michael Abecassis, Anton I. Skaro. The Increased Costs of Donation after Death Liver Transplantation: Caveat Emptor. Annals of Surgery. 2010 Apr; 251(4): 743-8.
  • Skaro AI, Jay CL, Ladner D, Abecassis MM. Trends in donation after cardiac death and donation after brain death–reading between the lines. Am J Transplant. 2010 Nov;10(11):2390-1
2009
  • Van Wagner LB, Baker T, Ahya SN, Norvell JP, Wang E, Levitsky J. Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. J Hepatol. 2009;51(5):874-80.
  • Skaro AI, Jay CL, Baker TB, Wang E, Pasricha S, Lyuksemburg V, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146(4):543-52; discussion 52-3.
  • Levitsky J, Doucette K. Viral hepatitis in solid organ transplant recipients. Am J Transplant. 2009;9 Suppl 4:S116-30.
  • Jay CL, Butt Z, Ladner DP, Skaro AI, Abecassis MM. A review of quality of life instruments used in liver transplantation. J Hepatol. 2009;51(5):949-59.
  • Baker TB, Jay CL, Ladner DP, Preczewski LB, Clark L, Holl J, et al. Laparoscopy-assisted and open living donor right hepatectomy: a comparative study of outcomes. Surgery. 2009;146(4):817-23; discussion 23-5.

NATIONAL PRESENTATIONS

2014
  • VanWagner L, Lapin B, Lloyd- Jones D, Skaro A, Rinella ME, editors. Early Cardiovascular Disease Mortality After Liver Transplantation-Is Nonalcoholic Steatohepatitis (NASH) to Blame? EASL- The International Liver Congress 2014; 2014; London, UK
2013
  • Goodmanson M, Nilles K, Ho B, Ison M, Levitsky J, editors. Colonoscopic evaluation of diarrhea and colitis in abdominal solid organ transplant recipients. CTC Summer Student Immersion Program Poster Session; 2013; Chicago, IL.
  • Baker T, Levitsky J, Al-Saden P, Solomon D, Ballard K, Jie C, et al., editors. Plasma Osteopontin Levels Correlate with Reversible Kidney Injury in Liver Transplant Candidates. American Transplant Congress; 2013; Seattle, WA.
2011
  • Jay CL, Lyuksemburg V, Ladner DP, Wang E, Holl J, Hazen G, et al., editors. The Comparative Effectiveness of Donation after Cardiac Death versus Donation after Brain Death Liver Transplantation: Recognizing Who Can Benefit. American Association for the Study of Liver Disease Annual Meeting; 2011 San Francisco, CA. .
  • Wang E, Lyuksemburg V, Abecassis MM, Skaro AI, editors. Donor and Recipient Risk Aversion in Liver Transplantation. American Association for the Study of Liver Disease Annual Meeting; 2011; San Francisco, CA.
  • Sundaram SS, Alonso E, Zeitler P, Yin W, Anand R, Group SR, editors. Obesity after Pediatric Liver Transplant: Prevalence and Risk Factors. American Transplant Congress; 2011; Philadelphia, PA.
  • Skaro A, Wang E, Lyuksemburg V, Ladner D, Jay C, Chang Y, et al., editors. Risk Aversion in Liver Transplantation – The Dark Side of Quality Improvement and Regulatory Oversight. Association for Academic Surgery/Society of University Surgeons American Surgical Congress; 2011; Huntington Beach, CA.
  • Di Sabato D, Caicedo J, Skaro A, Wang E, Superina R, editors. Outcomes of Liver Transplantation for the Small Infant – An Analysis of the National Registry. American Transplant Congress; 2011; Philadelphia, PA.
  • Beauvais N, Warren E, Tambur A, Leventhal J, Friedewald J, editors. Improved Efficiency with the Evolution of a Single Center Incompatible Kidney Program-Transition from Desensitization to Kidney Paired Donation. American Transplant Congress; 2011; Philadelphia, PA.
  • Baker T, editor. Midday Symposium: The DCD Liver Experience to Date: Outcome and Cost Implications of DCD Liver Transplantation – Innovative Strategies to Protect the DCD Liver. American Transplant Congress; 2011; Philadelphia, PA.
  • Skaro A, Jay C, Lyuksemburg V, Ladner D, Davis A, Mehrotra S. Liver Sharing – We Don’t Know What We Don’t Know. 7th Annual Lewis Landsberg Research Day 2011; Chicago, IL.
  • Skaro A, Ladner D, Jay C, Wang E, Lyuksemburg V, Ross O, et al. The Impact of Coronary Artery Disease on Outcomes after Liver Transplantation. Circulation 2011.
  • Skaro A, Li Z, Lyuksemburg V, Jay C, Ladner D, Abecassis M. The Societal Impact of Augmenting Donation after Cardiac Death Livers – Evaluating the Queue. 7th Annual Lewis Landsberg Research Day; 2011; Chicago, IL.
  • Skaro A, Ngoufanke T, Jay C, Ladner D, Lyuksemburg V, Abecassis M. The Societal Impact of Augmenting Donation after Cardiac Death Livers – Evaluating the Queue. American Transplant Congress; 2011; Philadelphia, PA.
  • Skaro A, Wang E, Lyuksemburg V, Ladner D, Jay C, Chang Y. Risk Aversion in Liver Transplantation – The Dark Side of Quality Improvement and Regulatory Oversight. Association for Academic Surgery/Society of University Surgeons American Surgical Congress; 2011; Huntington Beach, CA.
  • Ladner D, Gordon E, Ross O, Skaro A, Woods D, Butt Z. NUTORC: The Implementing of a Transdisciplinary Scientific Collaboration to Advance Transplantation Outcomes Research. AcademyHealth Annual Research Meeting; 2011; Seattle, Washington.
  • Ladner D, Ross O, Skaro A, Torricelli A, Ziomek R, Lyuksemburg V. Safety Issues Identified by Proactive Liver Transplant Safety Debriefing. American Association for the Study of Liver Disease Annual Meeting; 2011; San Francisco, CA.
  • Ladner D, Ross O, Skaro A, Woods D, Lakhoo K, Torricelli A. Safety Issues in Living Donor Kidney Transplant Identified through a Proactive Web-based Transplant Safety Debriefing Tool. AcademyHealth Annual Research Meeting; 2011; Seattle, Washington.
  • Ladner D, Ross O, Skaro A, Woods D, Torricelli A, Lyuksemburg V. Issues in Living Donor Kidney Transplant (LDKT) Identified by the NUTORC Proactive Transplant Safety Debriefing Tool. 7th Annual Lewis Landsberg Research Day; 2011; Chicago, IL.
  • Ladner D, Ross OA, Skaro AI, Woods D, Lyuksemburg V, Lakhoo K. Knowing the Enemy The First Step to Improving Safety in Living Donor Kidney Transplantation. American Society of Nephrology; 2011; Philidalphia, PA.
2010
  • Skaro A, Wang E, Jay C, Ladner D, Chang Y, Lyuksemburg V, et al., editors. Cardiovascular Risk Aversion in Renal Transplantation – An Unintended Consequence of Performance Measurement and Regulatory Oversight. American Society of Nephrology; 2010 Denver, CO.
  • Jay C, Skaro AI, Kang R, Preczewski L, Holl J, Abecassis MM, editors. The Comparative Effectiveness of Donation after Cardiac Death versus Donation after Brain Death Liver Transplant: The Cost & Quality Chasm. Northwestern University Department of Surgery Edelstone-Bendix Reseach Symposium; 2010 Chicago, IL.
  • Chang Y, Jay CL, Wang E, Lyuksemburg V, Ladner D, Holl JL, et al., editors. Evaluation of Candidate Guidelines for Combined Liver and Kidney (CLK) Transplantation – A Comparative Effectiveness Analysis. American Association for the Study of Liver Disease Annual Meeting; 2010 Boston, MA.
  • Lyuksemburg V, Wang E, Jay C, Chang Y, Ladner D, Caicedo J, et al., editors. Graft Failure from Hepatitis C Virus Recurrence – Does Graft Type Matter. American Association for the Study of Liver Disease Annual Meeting; 2010; Boston, MA. .
  • Lyuksemburg V, Jay C, Ladner D, Chang Y, Edward W, Caicedo J, et al., editors. The Impact of Donation after Cardiac Death Livers on Hepatitis C Virus Recurrence following Liver Transplantation. American Association for the Study of Liver Disease Annual Meeting; 2010; Boston, MA. .
  • Jay C, Skaro AI, Lyuksemburg V, Kang R, Ladner DP, Abecassis MM, editors. Mortality after Donation after Cardiac Death Liver Transplantation: An Analysis of the National Experience. Association for Academic Surgery/Society of University Surgeons American Surgical Congress; 2010; San Antonio, TX.
  • Jay C, Skaro A, Ladner D, Lyuksemburg V, Kang R, Xu H, et al., editors. The Incremental Benefit of Donation after Cardiac Death Liver Transplantation according to Candidate Disease Severity: A Decision Analysis. Association for Academic Surgery/Society of University Surgeons American Surgical Congress; 2010; San Antonio, TX.
2009
  • Skaro A, Jay C, Ladner D, Abecassis M, editors. The Impact of Coronary Risk Factors and Severity of Coronary Artery Disease on Outcomes After Liver Transplantation. American Association for the Study of Liver Diseases Annual Meeting; 2009 Boston, MA.
  • Jay C, Skaro A, Baker T, Pasricha S, Preczewski L, Wang E, et al., editors. Donation after Cardiac Death Liver Transplantation. Central Surgical Association Annual Meeting; 2009 Sarasota, FL. .
  • Baker T, Jay C, Ladner DP, Preczewski L, Clark L, Abecassis MM, editors. Laparoscopy-assisted and Open Living Liver Donation: A Comparison of Outcomes and Cost. Central Surgical Association Annual Meeting; 2009 Sarasota, FL.
  • Skaro A, Ross O, Ladner D, Woods D, Jay C, McNatt G, et al., editors. Incorporating Safety Risks in the Assessment of Health State Preferences for Living Donor Versus Deceased Donor Liver Transplantation. American Transplant Congress; 2009; Boston, MA.
  • Ng V, Martz K, Limbers C, Neighbors K, Anand R, Varni J, et al., editors. Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG). Health-Related Quality of Life after Pediatric Liver Transplantation for Acute Liver Failure: results from The SPLIT Functional Outcomes Group. American Association for the Study of Liver Diseases; 2009; Boston, MA.
  • Jay C, Skaro A, Kang R, Preczewski L, Holl J, Abecassis M, editors. The increased Costs of Donation after Cardiac Death Liver Transplantation: Caveat Emptor. National Research Service Award Conference; 2009; Chicago, IL.
2008
  • Sorenson L, Neighbors K, Marts K, Zelko F, Bucuvalas J, Alonso E, editors. Intellectual and academic outcomes following pediatric liver transplantation – preliminary results of the Functional Outcomes Group. American Association for the Study of Liver Diseases Annual Meeting; 2008; San Francisco, CA.